Julie Cooke Net Worth
Track Major Insider Updates On X/TwitterLast Updated: 13 hours ago
Julie Cooke has an estimated net worth of at least $15.3 million*, as of yesterday. They own 18,202 shares of NBIX stock. They have sold 105,475 shares of NBIX stock since 2021, for an estimated $13.0 million.
Julie Cooke $NBIX SEC Form 4 Insider Trading
Julie Cooke has filed a total of 34 insider trades in $NBIX since 2021. Their most recent trade was a sale of 12,632 shares, made on Aug 01, 2024. Their largest trade was a sale of 14,000 shares, made on Dec 22, 2023. We estimate that they now own 18,202 shares of $NBIX, worth an estimated $2.3 million.
Insider Trading at $NBIX
There have been a total of 272 insider trades reported at $NBIX since 2021, with 0 shares purchased and 1.7 million shares sold. The most active insider traders in $NBIX stock have been Julie Cooke, Eric Benevich, and Darin Lippoldt. The most recent trade was a sale of 1,295 shares reported by David W. Boyer (Chief Corp. Affairs Officer), made on Oct 03, 2024.
History of Insider Stock Trades by Julie Cooke
Company Ticker | Purchase / Sale | Shares | Date | Disclosed (EST) |
---|---|---|---|---|
NBIX | Sale | 12,632 | Aug 01, 2024 | Aug. 5, 2024, 5:40 p.m. |
NBIX | Sale | 900 | Jul 16, 2024 | July 18, 2024, 5:12 p.m. |
NBIX | Sale | 10,000 | Jul 01, 2024 | July 2, 2024, 9:36 p.m. |
NBIX | Sale | 796 | Feb 13, 2024 | Feb. 15, 2024, 6:35 p.m. |
NBIX | Sale | 700 | Feb 08, 2024 | Feb. 8, 2024, 8:35 p.m. |
NBIX | Sale | 640 | Feb 06, 2024 | Feb. 8, 2024, 8:35 p.m. |
NBIX | Sale | 575 | Feb 06, 2024 | Feb. 8, 2024, 8:35 p.m. |
NBIX | Sale | 629 | Feb 08, 2024 | Feb. 8, 2024, 8:35 p.m. |
NBIX | Sale | 916 | Jan 31, 2024 | Feb. 2, 2024, 8:11 p.m. |
NBIX | Sale | 824 | Jan 31, 2024 | Feb. 2, 2024, 8:11 p.m. |
NBIX | Sale | 14,000 | Dec 22, 2023 | Dec. 27, 2023, 5:08 p.m. |
NBIX | Sale | 10,000 | Dec 22, 2023 | Dec. 27, 2023, 5:08 p.m. |
NBIX | Sale | 824 | Sep 01, 2023 | Sept. 6, 2023, 4:22 p.m. |
NBIX | Sale | 2,132 | Aug 21, 2023 | Aug. 23, 2023, 8:03 p.m. |
NBIX | Sale | 11,397 | May 01, 2023 | May 3, 2023, 5:28 p.m. |
NBIX | Sale | 100 | Apr 25, 2023 | April 27, 2023, 4:37 p.m. |
NBIX | Sale | 628 | Feb 08, 2023 | Feb. 8, 2023, 8:56 p.m. |
NBIX | Sale | 640 | Feb 06, 2023 | Feb. 8, 2023, 8:56 p.m. |
NBIX | Sale | 575 | Feb 06, 2023 | Feb. 8, 2023, 8:56 p.m. |
NBIX | Sale | 913 | Feb 07, 2023 | Feb. 8, 2023, 8:56 p.m. |
NBIX | Sale | 12,801 | Feb 07, 2023 | Feb. 8, 2023, 8:56 p.m. |
NBIX | Sale | 822 | Feb 07, 2023 | Feb. 8, 2023, 8:56 p.m. |
NBIX | Sale | 700 | Feb 08, 2023 | Feb. 8, 2023, 8:56 p.m. |
NBIX | Sale | 916 | Jan 31, 2023 | Feb. 2, 2023, 6:07 p.m. |
NBIX | Sale | 5,592 | Nov 08, 2022 | Nov. 10, 2022, 6:47 p.m. |
NBIX | Sale | 1,144 | Nov 02, 2022 | Nov. 4, 2022, 5:02 p.m. |
NBIX | Sale | 7,264 | Nov 03, 2022 | Nov. 4, 2022, 5:02 p.m. |
NBIX | Sale | 1,816 | Aug 05, 2022 | Aug. 9, 2022, 2:54 p.m. |
NBIX | Sale | 754 | Jun 27, 2022 | June 29, 2022, 4:26 p.m. |
NBIX | Sale | 605 | Feb 07, 2022 | Feb. 9, 2022, 7:55 p.m. |
NBIX | Sale | 913 | Feb 07, 2022 | Feb. 9, 2022, 7:55 p.m. |
NBIX | Sale | 640 | Feb 07, 2022 | Feb. 9, 2022, 7:55 p.m. |
NBIX | Sale | 700 | Feb 08, 2022 | Feb. 9, 2022, 7:55 p.m. |
NBIX | Sale | 987 | Oct 04, 2021 | Oct. 5, 2021, 8 p.m. |
$NBIX Executives and Stock Owners with Insider Trades
-
Julie Cooke, Chief Human Resources Officer
-
Eric Benevich, Chief Commercial Officer
-
Darin Lippoldt, Chief Legal Officer
-
Eiry Roberts, Chief Medical Officer
-
David W. Boyer, Chief Corp. Affairs Officer
-
Ingrid Delaet, Chief Regulatory Officer
-
Matt Abernethy, Chief Financial Officer
-
Kyle Gano, Chief Business Development Off
-
Kevin Charles Gorman, Chief Executive Officer
-
Jude Onyia, Chief Scientific Officer
-
Malcolm Lloyd-Smith, Chief Regulatory Officer
-
Malcolm Lloyd-Smith, Chief Integration Officer
-
Dimitri E. Grigoriadis, Chief Research Officer
*This is only based off of information found in SEC filings, and may not reflect actual net worth. There may also be inaccuracies due to privately holdings filing errors, parsing errors, accidental double-counting of shares, incorrect classification of indirectly owned shares, sales prior to dataset start date, or any other number of issues.